Latest News

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Cancer, gliblastoma, Neuro-oncology, Brain Tumor

Ludwig Scientists Share Findings on Development and Treatment of Glioblastoma at the 2017 Society for Neuro-Oncology Annual Meeting

Ludwig Cancer Research has released the scope of its participation at this year’s Annual Meeting and Education Day of the Society for Neuro-Oncology in San Francisco, California, November 16-19.

Medicine

Channels:

Melanoma, Immunotherapy, Apoptosis, FAS

Ludwig Researchers Uncover Novel Mechanism by Which Tumors Evade a Variety of Cancer Immunotherapies

A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumors of the aggressive skin cancer melanoma can resist cancer immunotherapy.

Medicine

Channels:

Immunotheapy, PD-1, Tumor Microenvironment

Ludwig Scientists Share Insights on Immunotherapy Research at the 2017 Society for Immunotherapy of Cancer Annual Meeting

Ludwig Cancer Research has released the scope of its participation at the 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting in National Harbor, Maryland, November 8-12.

Medicine

Channels:

Acute Promyelocytic Leukemia, Immune Cells, immune suppression, Prostate Cancer

Ludwig Scientists Discover Complex Axis of Immune Suppression Exploited by Cancers

A Ludwig Cancer Research study has uncovered a new mechanism by which cancer cells evade destruction by the immune system. The paper, led by Camilla Jandus of the Lausanne Branch of the Ludwig Institute for Cancer Research, describes how immune cells known as group 2 innate lymphoid cells (ILC2s) are recruited by leukemic cells to suppress an essential anticancer immune response.

Medicine

Channels:

Drug Resistance, Breast Cancer, Cancer Diagnosis, Microscopy, Cancer Research

A Swell Diagnostic Method

Ludwig researchers show how a method that physically expands tissues can improve early breast cancer diagnostics and extend the capabilities of ordinary pathology labs

Medicine

Channels:

ASCO 2017, ASCO, Immunotheapy, Immunotherapy Clinical Trials, ASCO Annual Meeting

Ludwig Researchers Present New Findings on Combination Immunotherapy and Other Research at the 2017 ASCO Annual Meeting

Ludwig Cancer Research released today the full scope of Ludwig’s participation at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 2-6.

Medicine

Channels:

Brain Cancer, Gliobastoma, PTEN

Ludwig Researchers Identify Counterintuitive Approach to Treating a Brain Cancer

Furnariheadshot5.12.17.jpg

The loss of the tumor suppressor gene PTEN has been linked to tumor growth and chemotherapy resistance in the almost invariably lethal brain cancer glioblastoma multiforme (GBM). Now, Ludwig researchers have shown that one way to override the growth-promoting effects of PTEN deletion is, surprisingly, to inhibit a separate tumor suppressor gene.

Medicine

Channels:

AACR 2017, AACR Annual Meeting 2017, AACR, Aacr Annual Meeting, Cancer, liquid biopsies, Immunotheapy, treatment resistance

Ludwig Scientists Reveal New Advances in Immunotherapy, Biomarkers and Treatment Resistance at 2017 AACR Annual Meeting

Ludwig Cancer Research released today the full scope of advances to be presented by Ludwig researchers at this year’s American Association for Cancer Research (AACR) Annual Meeting in Washington D.C., April 1-5, 2017.

Medicine

Channels:

Breast Cancer, Cancer, Combination Therapy, Combination Treatment, DNA

A Vulnerability in Triple-Negative Breast Cancer Could Improve Treatment Outcomes

Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.

Science

Channels:

Cancer, Tumor, DNA, ecDNA, Genomics, Tumor Cells, Bioinfomatics

New Ludwig Research Will Shift How Cancer Diversity and Resistance Are Understood and Studied

Mischel.jpg.jpeg

Ludwig researchers discover that circular DNA, once thought to be rare in tumor cells, is actually very common and seems to play a fundamental role in tumor evolution







Chat now!